当前位置:首页 - 行情中心 - 丰原药业(000153) - 财务分析 - 现金流量表

丰原药业

(000153)

  

流通市值:30.49亿  总市值:31.33亿
流通股本:4.52亿   总股本:4.65亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,601,266,628.71781,358,331.183,463,113,510.182,682,758,366.83
  收到的税费返还2,414,216.281,531,336.315,029,097.814,074,290.75
  收到其他与经营活动有关的现金38,986,235.9122,101,897.04337,844,690.6494,772,188.83
  经营活动现金流入小计1,642,667,080.9804,991,564.533,805,987,298.632,781,604,846.41
  购买商品、接受劳务支付的现金1,101,849,947.52508,020,372.032,358,196,622.091,900,477,701.74
  支付给职工以及为职工支付的现金210,708,151.68123,655,072.29419,822,145.05311,121,720.76
  支付的各项税费104,726,728.1756,419,902.11211,772,462.27167,440,399.7
  支付其他与经营活动有关的现金197,239,363.61104,563,902.87689,960,920.01334,104,683.94
  经营活动现金流出小计1,614,524,190.98792,659,249.33,679,752,149.422,713,144,506.14
  经营活动产生的现金流量净额28,142,889.9212,332,315.23126,235,149.2168,460,340.27
二、投资活动产生的现金流量:
  收回投资收到的现金1,400,0001,400,00025,816,556.625,816,556.6
  取得投资收益收到的现金--9,271,305.329,193,618.5
  处置固定资产、无形资产和其他长期资产收回的现金净额29,772.758,898.75473,786382,700
  投资活动现金流入小计1,429,772.751,408,898.7535,561,647.9235,392,875.1
  购建固定资产、无形资产和其他长期资产支付的现金133,351,252.9391,534,251.72144,015,906.34104,042,277.56
  投资支付的现金--143,000,472.47113,000,000
  投资活动现金流出小计133,351,252.9391,534,251.72287,016,378.81217,042,277.56
  投资活动产生的现金流量净额-131,921,480.18-90,125,352.97-251,454,730.89-181,649,402.46
三、筹资活动产生的现金流量:
  吸收投资收到的现金--4,660,0002,700,000
  其中:子公司吸收少数股东投资收到的现金--4,660,0002,700,000
  取得借款收到的现金656,357,601.84328,585,943.071,155,685,392.17816,815,268.28
  筹资活动现金流入小计656,357,601.84328,585,943.071,160,345,392.17819,515,268.28
  偿还债务支付的现金513,894,188231,000,0001,002,755,589.58690,549,000
  分配股利、利润或偿付利息支付的现金60,853,537.087,184,098.3872,171,16069,512,022.39
  支付其他与筹资活动有关的现金13,423,842.426,643,022.1734,792,295.6727,116,534.61
  筹资活动现金流出小计588,171,567.5244,827,120.551,109,719,045.25787,177,557
  筹资活动产生的现金流量净额68,186,034.3483,758,822.5250,626,346.9232,337,711.28
四、汇率变动对现金及现金等价物的影响-2,953.17742.75166,346.1598,900.55
五、现金及现金等价物净增加额-35,595,509.095,966,527.53-74,426,888.61-80,752,450.36
  加:期初现金及现金等价物余额216,312,023.86216,312,023.86290,738,912.47290,738,912.47
  期末现金及现金等价物余额180,716,514.77222,278,551.39216,312,023.86209,986,462.11
补充资料:
  净利润75,002,400.41-157,650,906.74-
  资产减值准备6,096,773.37-14,950,908.74-
  固定资产和投资性房地产折旧52,104,741.5-87,650,171.72-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧52,104,741.5-87,650,171.72-
  无形资产摊销7,823,891.96-13,138,500.23-
  长期待摊费用摊销7,407,372.43-16,095,598.24-
  处置固定资产、无形资产和其他长期资产的损失--1,613,956.1-
  固定资产报废损失59,287.73-8,906.97-
  公允价值变动损失710,807.5-5,283,485.49-
  财务费用15,874,108.64-30,246,938.07-
  投资损失600--9,220,093.88-
  递延所得税-2,069,409.76--1,258,029.94-
  其中:递延所得税资产减少-2,274,207.45-1,249,375.66-
    递延所得税负债增加204,797.69--2,507,405.6-
  存货的减少34,721,375.65--18,380,039.34-
  经营性应收项目的减少-154,789,138.12--165,390,536.11-
  经营性应付项目的增加-26,763,941.47--33,202,668.52-
  其他-1,753,112.03---
  现金的期末余额180,716,514.77-216,312,023.86-
  减:现金的期初余额216,312,023.86-290,738,912.47-
  现金及现金等价物的净增加额-35,595,509.09--74,426,888.61-
公告日期2025-08-222025-04-252025-04-112024-10-31
审计意见(境内)标准无保留意见
TOP↑